These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 2851444)

  • 1. Cytotoxicity of 4-hydroxyanisole and tyrosinase activity in variant cell lines of B16 melanoma.
    Thody AJ; Oliver I; Sherbet GV
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1879-84. PubMed ID: 2851444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A; Moellmann G; Kuklinska E
    J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB; Lunsford JB; Iman DS
    J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of growth inhibition of melanoma by 4-hydroxyanisole.
    Kulkarni GA; Nathanson L
    Pigment Cell Res; 1989; 2(1):40-3. PubMed ID: 2497444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH; Lee MS
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
    Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid blockade of imidazole-induced tyrosinase expression in B16 melanoma cultures: similar effects of the active retinoid and triiodothyronine.
    Smith TJ; Warren JT; Kline EL
    Biochem Biophys Res Commun; 1989 Jul; 162(1):288-93. PubMed ID: 2502111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-hormonal regulation of tyrosinase expression in B16/C3 melanoma cells in culture.
    Smith TJ; Kline EL
    Prog Clin Biol Res; 1988; 262():241-55. PubMed ID: 3131777
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-selective action of 4-hydroxyanisole on melanoma cells in vivo.
    Schwabe K; Fichtner I; Tschiersch B
    Pigment Cell Res; 1990; 3(1):8-10. PubMed ID: 2116000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major primary cytotoxic product of 4-hydroxyanisole oxidation by mushroom tyrosinase is 4-methoxy ortho benzoquinone.
    Naish S; Holden JL; Cooksey CJ; Riley PA
    Pigment Cell Res; 1988; 1(6):382-5. PubMed ID: 3148922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle.
    Fuller BB; Brooks BA
    Exp Cell Res; 1980 Mar; 126(1):183-90. PubMed ID: 6766870
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructural and biochemical observations on the effect of 4-hydroxyanisole plus tyrosinase on normal human melanocytes and keratocytes in tissue culture.
    Breathnach A; Robins E; Ethridge L; Bhasin Y; Gallagher S; Passi S; Nazzaro-Porro M
    Br J Cancer; 1983 Jun; 47(6):813-22. PubMed ID: 6407506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.